PersonalEmployment Agreement

EX-10.6 15 v200830_ex10-6.htm EMPLOYMENT AGREEMENT
EXHIBIT 10.6
 
Personal Employment Agreement

 
This Personal Employment Agreement (the Agreement”) is entered as of this 18th day of March, 2007 (the “Effective Date”), by and between
 
MEDGENICS MEDICAL ISRAEL LTD.,
 
a company organized under the laws of the State of Israel, private company number ###-###-####,
 
having its principal office at 12 HaNapach St, Karmiel, 21653
 
(the “Company”); and
 
STEPHEN BELLOMO
 
of Rechov Itzhak Sadeh 7 Zichron Ya’akov 30900, Israel (Israeli I.D. No. 313669509)
 
(the Employee”).

 
WITNESSETH
 
 
WHEREAS,
the Company was established for the purpose of engaging in the research and development, production and sale of products and/or services in the areas of life sciences, biotechnology and/or medical devices; and
 
 
WHEREAS,
the Company desires to engage the Employee as Vice President Program Management and Product Development; and
 
 
WHEREAS, 
the Employee represents that he has the requisite skill and knowledge to serve as such; and
 
 
WHEREAS, 
the parties desire to state the terms and conditions of the Employee’s engagement by the Company, effective as of the Effective Date, as set forth below.
 
 
NOW THEREFORE, in consideration of the mutual promises, covenants, conditions, representations
 
 

 
and warranties set forth herein, and intending to be legally bound hereby, the parties agree as follows:
 
1. 
Appointment
 
The Company hereby appoints the Employee as Vice President Program Management and Product Development of the Company and, in such capacity, the Employee shall be subject to the direction of the Company’s Chief Executive Officer (the “CEO”).
 
2. 
Position
 
During the term of this Agreement:
 
2.1
The Employee shall be employed on a full-time basis and shall devote his entire business time, attention and efforts to the performance of his duties and responsibilities under this Agreement and the business and affairs of the Company. The Employee may not be employed by nor provide services to any other entity, nor engage directly or indirectly in any other work or business, without the prior, express, written permission of the Company.
 
2.2
The Employee shall be responsible for (i) coordinating the overall execution of the Company’s business plan, as adopted by the Company’s Board of Directors (the Board”), in cooperation and coordination with the CEO and other members of management, and (ii) product development, including specific responsibility for design and development of all devices and their related materials and assembling and leading the product development team.
 
2.3
The duties, responsibilities, authority and position of the Employee and the organizational structures implicit in them may be changed by the Company from time to time, as the CEO deems necessary, and reasonable efforts to work with and accommodate the Employee with such changes will be made; however, the Employer retains the right of sole discretion to make such changes.
 
2.4
The Employee acknowledges hereby that the terms of his employment, the circumstances thereof, and the nature of his work require an unusual amount of personal

 
2

 
 
trust as set out in the law governing Hours of Employment and Rest Law; 5711-1951, and, therefore, said law shall not apply to his employment with the Company.
 
2.5
The Employee’s weekly day of rest shall be Saturday. The Employee shall not perform any work on the Jewish Sabbath (beginning Friday evening) or Jewish holidays unless authorized to do so by the Company in advance.
 
2.6
The Employee shall have no authority toward third parties on behalf of the Company and may not execute any agreements or contracts which bind the Company, without the prior, express, written authorization of the CEO or of the Board of Directors of the Company.
 
2.7
The Employee undertakes to notify the Company, immediately and without delay, of any interest or matter in respect of which he may have a personal interest or is likely to create a conflict of interest with his role in the Company.
 
3. 
Place of Work
 
In connection with the Employee’s employment by the Company, the Employee shall be based at the current principal offices of the Company in Israel, or at such other place as is otherwise appropriate to the functions being performed by the Company.  The Employee acknowledges that the performance of his duties hereunder may require domestic or international travel.
 
4. 
Salary; Bonus
 
4.1
The Company shall pay the Employee as compensation for the employment services hereunder a monthly gross salary (“bruto”) of NIS 40,200 per month (payable in arrears on the ninth day of each month), during the term of the Employee’s engagement hereunder (the “Salary”). The Company shall deduct taxes and other obligatory payments at source, in accordance with all applicable law.
 
4.2
The Salary and additional benefits to which the Employee shall be entitled hereunder (including bonuses) shall be reviewed by the CEO on an annual basis; and, in the CEO’s sole discretion and subject to the approval of the Board, the Employee’s Salary may be adjusted and/or additional benefits shall be granted to the Employee hereunder.
 
4-3 
Potential Bonus Related to Achievement of Company Goals. The Employee shall be

 
3

 
eligible to receive an annual cash bonus with respect to each fiscal year of the Company during the Term of up to $20,000 on an annualized basis, as determined by the Board, in its sole discretion, which shall be based upon corporate and personal performance criteria as established by the CEO and the Board (the “Goal Bonus”). If awarded, the Goal Bonus shall be payable within ninety (90) days after the end of the fiscal year to which it relates. The performance criteria for the Goal Bonus for 2007 is set forth on Exhibit A attached hereto.

4.4 
Potential Bonus Related to Team Leadership. The Employee shall be eligible to receive an annual cash bonus with respect to each fiscal year of the Company during the Term of up to $15,000 on an annualized basis, as determined by the Board, in its sole discretion, which shall be based upon personal and team leadership performance criteria as established by the CEO and the Board (the “Team Leadership Bonus”). If awarded, the Team Leadership Bonus shall be payable within ninety (90) days after the end of the fiscal year to which it relates. The criteria for the Team Leadership Bonus for 2007 is set forth on Exhibit B attached hereto.
 
5. 
Social Insurance and Benefits
 
5.1
The Company shall insure the Employee under an accepted “Manager’s Insurance Scheme” and/or a comprehensive financial arrangement, at the election of the Employee, including insurance in the event of illness or loss of capacity for work (hereinafter referred to as the “Managers Insurance”) as follows: (a) the Company shall pay an amount equal to 5% of the Employee’s Salary towards the Managers Insurance or pension plan for the Employee’s benefit and shall deduct 5% from the Employee’s Salary and pay such amount towards the Managers Insurance or pension plan for the Employee’s benefit (division among the various components shall be fixed at the discretion of the Employee subject to legal limitations); (b) the Company shall pay up to 2.5% of the Employee’s Salary towards disability insurance; and (c) the Company shall pay an amount equal to 8 1/3% of the Employee’s Salary towards a fund for severance compensation which shall be payable to the Employee upon severance, but subject to the provisions of Section 7.3.

 
4

 
5.2
The Company shall pay the full Salary of the Employee, including benefits hereunder, during the period of the Employee’s military reserve service (but not including “Shlav Bet” service). National Insurance Institute transfers in connection with such military reserve duty shall be retained by the Company. The Employee shall provide the Company with a valid certificate from the IDF as necessary to receive National Insurance payments as aforesaid (Form 3010).
 
5.3
The Company and the Employee shall open and maintain a Keren Hishtalmut Fund. The Company shall contribute to such Fund an amount equal to 7.5% of each monthly Salary payment, but not more than the amount for which the Employee is exempt from tax, and the Employee shall contribute to such Fund an amount equal to 2-1/2% of each monthly Salary payment, subject to said tax limitation. The Employee hereby instructs the Company to transfer to such Fund the amount of the Employee’s and the Company’s contribution from each monthly Salary payment.
 
6. 
Additional Benefits
 
6.1
The Employee shall be entitled to be reimbursed for all normal, usual and necessary actual business expenses arising out of travel, lodging, meals and entertainment whether in Israel or abroad, provided Employee provides proper documentation and provided further that such business expenses are within an expense policy approved by the Board,
 
6.2
The Employee shall be entitled, in addition to public holidays, to 22 (twenty-two) paid vacation days, calculated on the basis of a five-day work-week. A maximum of one year’s entitlement to vacation days may be accumulated if unused, beyond which any vacation days will be forfeited by the Employee if not utilized during the year in which they are allocated,.
 
6.3
Employee shall be entitled to sick leave and Recreation Pay (Dmei Havra-ah) according to applicable law.
 
6.4
As soon as practicable after the Effective Date and subject to the approval of the Board, the Employee shall be granted options to purchase up to 70,000 shares of the Company’s common stock pursuant to the Company’s Incentive Stock Plan, as the same may be amended.   Such options shall vest in four (4) equal annual installments, with

 
5

 
options to purchase the first 17,500 shares vesting upon the first anniversary of the Effective Date. Such options shall have a five-year term and an exercise price of $2.50 per share and shall be subject to the terms and conditions of the Company’s Incentive Stock Plan, as the same may be amended, and pursuant to the standard form of option agreement which the Company may use. Upon termination of employment for any reason, all unvested options shall expire.
 
6.5
The Employee will be entitled at the Company’s expense to the use of a company car, of a type Group 2, under other conditions to be determined by the Company. For avoidance of doubt, all income taxes associated with such car’s “value equivalent” for tax purposes (the value of the car usage as determined by the tax authorities) shall be borne by the Employee and deducted from the salary. Employee shall at all times comply with any Company rules with respect to the use of the company vehicle. Any driving and/or parking fines incurred while the vehicle was provided for the use of the Employee shall be the sole responsibility of the Employee, and Employee hereby empowers the Company to sign any documents necessary to formally assign any such fines and/or tickets to Employee’s name.
 
6.6
Any tax liability in connection with the options (including with respect to the grant, exercise, sale of the options or the shares receivable upon their exercise) shall be borne solely by the Employee.
 
7. 
Termination
 
7.1
This Agreement shall commence as of the Effective Date and shall continue unless this Agreement is terminated as hereafter provided.
 
7.2
Termination Without Cause - The Company may terminate this Agreement and the employment relationship hereunder at its discretion and at any time by giving Employee 2 (two) months prior written notice. Employee may terminate this Agreement and the employment relationship hereunder at his discretion and at any time by giving the Company 2 (two) months prior written notice.

 
 
6

 
In the event of termination of employment by the Company, the Company may, at its discretion, determine that the Employee’s employment shall cease immediately or at any time prior to expiration of the prior notice period, and in such event the Company shall pay the Employee an amount equal to the salary which would have been paid during the remaining prior notice period.
 
7.3
Termination With Cause - The Company may terminate the Employee’s employment immediately upon written notice for cause. For purposes of this Agreement, termination for “cause” shall mean and include: (a) conviction of a felony involving moral turpitude or affecting the Company, or its subsidiaries; (b) any refusal to carry out a reasonable directive of the CEO or the Board which involves the business of the Company or its subsidiaries and was capable of being lawfully performed; (c) embezzlement of funds of the Company or its subsidiaries; (d) any breach of the Employee’s fiduciary duties or duties of care to the Company (except for conduct taken in good faith); (e) any breach of this Agreement by the Employee and the failure to cure the same to the satisfaction of the Company within fifteen days of written notice from the Company specifying in reasonable detail such breach; or (f) any conduct (other than in good faith) materially detrimental to the Company or its subsidiaries, including, but not limited to, sexual harassment and violence. If the employment of the Employee is terminated for cause, then the Employee shall not be entitled to severance pay.
 
7.4
Termination Upon Death or Disability - The Company may terminate the Employee’s employment upon the death of the Employee or after having established the Employee’s disability. For purposes of this Agreement, “disability” means a physical or mental infirmity that impairs the Employee’s ability to substantially perform his duties under the Agreement that continues for a period of at least ninety (90) consecutive days.
 
7.5
From and after the delivery of a notice of termination by either the Employee or the Company, the Employee shall, at the Company’s request, cooperate with the Company and use his best efforts to assist in the integration into the Company’s organization the person or persons who will assume the Employee’s responsibilities.

 
 
7

 
8. 
Proprietary Information
 
8.1
The Employee acknowledges and agrees that he may have access to confidential and/or proprietary information concerning the business and financial activities of the Company and information and technology regarding the Company’s product research and development, including, without limitation, the Company’s banking, investments, investors, properties, employees, marketing plans, customers, trade secrets, and test results, processes, data and know-how, improvements, inventions, techniques and products (actual or planned). Such information, whether documentary, written, oral or computer generated, even if not patentable, or not protectable or protected by copyright laws, shall be deemed to be and is referred to as “Proprietary Information”.

8.2 
Proprietary Information shall be deemed to include any and all proprietary information disclosed by or on behalf of the Company and irrespective of form, but excluding information that (a) was known to the Employee prior to his association with the Company and can be so proven; (b) shall have become a part of the public domain except as a result of a breach of this Agreement by the Employee; (c) shall have been received by the Employee from a third party having no obligation to the Company.
 
8.3
The Employee agrees and declares that all Proprietary Information, patents and other rights in connection therewith shall be the sole property of the Company and its assigns. At all times, both during and after the termination of his employment with the Company for any reason, the Employee will keep in strict confidence and trust all Proprietary Information, and the Employee will not use, disclose or provide access to any Proprietary Information or anything relating to it without the written consent of the Board.
 
8.4
Upon termination of his employment with the Company, the Employee will promptly deliver to the Company all documents and materials of any nature pertaining to his work with the Company, and he will not take with him any documents or materials or copies thereof containing any Proprietary Information.
 
8.5
The Employee recognizes that the Company has received and may receive confidential or proprietary information from third parties subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited

 
 
8

 
purposes. At all times, both during and after the termination of his employment with the Company for any reason, the Employee undertakes to keep and hold all such information in strict confidence and trust, and he will not use, disclose or provide access to any of such information without the prior written consent of the Board, except as may be necessary to perform his duties as an employee of the Company and consistent with the Company’s agreement with such third party. Upon termination of his employment with the Company, Employee shall act with respect to such information as set forth in Section 8.4, mutatis mutandis.

8.6
The Employee’s undertakings in this Section 8 shall remain in full force and effect after termination of this Agreement or any renewal thereof.
 
9. 
Disclosure and Assignment of Inventions
 
9.1
The Employee understands that the Company is engaged in a continuous program of research, development, production and marketing in connection with its business and that, as an essential part of his employment with the Company, he is expected to make new contributions to and create inventions of value for the Company. Employee agrees to share with the Company all his knowledge and experience, provided however that Employee shall not disclose to the Company any information which Employee has undertaken to third parties to keep confidential or in which third parties have any rights.
 
9.2
As of the Effective Date of this Agreement, the Employee undertakes and covenants that he will promptly disclose in confidence to the Company all inventions, improvements, designs, original works of authorship, formulas, concepts, techniques, methods, systems, processes, compositions of matter, computer software programs, databases, mask works, and trade secrets, related to the Company’s business or current or anticipated research and development, whether or not patentable, copyrightable or protectible as trade secrets, that are made or conceived or first reduced to practice or created by him, either alone or jointly with others, during the period of his employment, whether or not in the course of his employment (“Inventions”).
 
9.3
The Employee agrees that all Inventions that (a) are developed using equipment, supplies, facilities or Proprietary Information of the Company, (b) result from work performed by him for the Company, or (c) relate to the Company’s business or current or

 
9

 
anticipated research and development, will be the sole and exclusive property of the Company (“Company Inventions”).
 
9.4
The Employee hereby irrevocably transfers and assigns to the Company: (a) all worldwide patents, patent applications, copyrights, mask works, trade secrets and other intellectual property rights in any Company Invention; and (b) any and all “Moral Rights” (as defined below) that he may have in or with respect to any Company Invention. He also hereby forever waives and agrees never to assert any and all Moral Rights he may have in or with respect to any Company Invention, even after termination of his work on behalf of the Company. “Moral Rights” mean any rights of paternity or integrity, any right to claim authorship of an invention, to object to any distortion, mutilation or other modification of, or other derogatory action in relation to, any invention, whether or not such would be prejudicial to his honor or reputation, and any similar right, existing under judicial or statutory law of any country in the world, or under any treaty, regardless of whether or not such right is denominated or generally referred to as a “moral right”. The Employee will not file any patent applications for Company Inventions other than in the name of the Company (other than such patent applications which are required by law to be filed by such Employee but which shall immediately thereafter be assigned for no or nominal consideration to the Company).
 
9.5 
The Employee agrees to assist the Company in every proper way to obtain for the Company and enforce patents, copyrights, mask work rights, and other legal protections for the Company’s Inventions in any and all countries. He will execute any documents that the Company may reasonably request for use in obtaining or enforcing such patents, copyrights, mask work rights, trade secrets and other legal protections. His obligations under this Section 9.5 will continue beyond the termination of his employment with the Company, provided that the Company will compensate him at a reasonable rate after such termination for time or expenses actually spent by him at the Company’s request on such assistance. The Employee hereby irrevocably appoints the CEO of the Company, including future CEO’s or corresponding officers of the Company or successor companies, as his attorney-in-fact to execute documents on his behalf for this purpose.
 
9.6
The Employee’s undertakings in this Section 9 shall remain in full force and effect after termination of this Agreement or any renewal thereof.

 
 
 
10

 
10. 
Non-Competition
 
10.1
The Employee agrees and undertakes that he will not, so long as he is employed by the Company and for a period of 12 months following termination of his employment for whatever reason, directly or indirectly, as owner, partner, joint venturer, stockholder, employee, broker, agent, principal, corporate officer, director, licensor or in any other capacity whatever engage in, become financially interested in, be employed by, or have any connection with any business or venture that is engaged in any activities competing with products or services offered by the Company; provided, however, that the Employee may own securities of any corporation which is engaged in such business and is publicly owned and traded but in an amount not to exceed at any one time one percent of any class of stock or securities of such company, so long as he has no active role in the publicly owned and traded company as director, employee, consultant or otherwise.
 
10.2
The Employee agrees and undertakes that during the period of his employment and for a period of 12 months following termination, he will not, directly or indirectly, including personally or in any business in which he is an officer, director or shareholder, for any purpose or in any place, solicit, assist in soliciting or employ any person employed by the Company or retained by the Company as a consultant, or any customer or supplier of the Company, on the date of such termination or during the preceding five months.
 
10.3
If any one or more of the terms contained in this Section 10 shall for any reason be held to be excessively broad with regard to time, geographic scope or activity, the term shall be construed in a manner to enable it to be enforced to the extent compatible with applicable law.
 
10.4
The Employee’s undertakings in this Section 10 shall remain in full force and effect after termination of this Agreement or any renewal thereof.
 
11. 
Rights Upon Termination
 
Upon termination of this Agreement by the Company for any reason whatsoever other than by justifiable cause, as defined herein, the Employee shall be entitled to the payment of his full salary, including insurance and social benefits as set for in Sections 4-6 above, during a period of 4 months if his employment is terminated with the first 12 months of the effective date, and
 
11

 
an additional month for each 12 months of employment thereafter.
 
12. 
Mutual Representations
 
12.1
The Employee represents and warrants to the Company that the execution and delivery of this Agreement and the fulfillment of the terms hereof (a) will not constitute a default under or conflict with any agreement or other instrument to which he is a party or by which he is bound, and (b) do not require the consent of any person or entity.
 
12.2
The Company represents and warrants to the Employee that this Agreement has been duly authorized, executed and delivered by the Company and that the fulfillment of the terms hereof (a) will not constitute a default under or conflict with any agreement or other instrument to which it is a party or by which it is bound, and (b) do not require the consent of any person of entity.
 
12.3
Each party hereto warrants and represents to the other that this Agreement constitutes the valid and binding obligation of such party enforceable against such party in accordance with its terms subject to applicable bankruptcy, insolvency, moratorium and similar laws affecting creditors’ rights generally, and subject, as to enforceability, to general principles of equity (regardless if enforcement is sought in proceeding in equity or at law).
 
13. 
Notice; Addresses
 
13.1
The addresses of the parties for purposes of this Agreement shall be the addresses set forth above, or any other address which shall be provided by due notice.
 
13.2
All notices in connection with this Agreement shall be sent by registered mail or delivered by hand to the addresses set forth above, and shall be deemed to have been delivered to the other party at the earlier of the following two dates: if sent by registered mail, as aforesaid, three business days from the date of mailing; if delivered by hand, upon actual delivery or proof of delivery (in the event of a refusal to accept it) at the address of the addressee. Delivery by facsimile or other electronic mail shall be sufficient and be deemed to have occurred upon electronic confirmation of receipt.
 
 
12

 
14 
Miscellaneous
 
14.1 
The preamble to this Agreement constitutes an integral part hereof.
 
14.2
Headings are included for reference purposes only and are not to be used in interpreting this Agreement.
 
14.3
The provisions of this Agreement are in lieu of the provisions of any collective bargaining agreement, and therefore, no collective bargaining agreement shall apply with respect to the relationship between the parties hereto (subject to the applicable provisions of law).
 
14.4
No failure, delay or forbearance of either party in exercising any power or right hereunder shall in any way restrict or diminish such party’s rights and powers under this Agreement, or operate as a waiver of any breach or nonperformance by either party of any terms or conditions hereof.
 
14.5
Any determination of the invalidity or unenforceability of any provision of the Agreement shall not affect the remaining provisions hereof unless the business purpose of this Agreement is substantially frustrated thereby.
 
14.6
This Agreement is personal and non-assignable by the Employee. It shall inure to the benefit of any corporation or other entity with which the Company shall merge or consolidate or to which the Company shall lease or sell all or substantially all of its assets, and may be assigned by the Company to any affiliate of the Company or to any corporation or entity with which such affiliate shall merge or consolidate or which shall lease or acquire all or substantially all of the assets of such affiliate. Any assignee must assume all the obligations of the Company hereunder, but such assignment and assumption shall not serve as a release of prior agreements, promises, covenants, arrangements, communications, or representations of the Company.
 
14.7
The Employee is obligated to keep all the terms and covenants of this Agreement under strict confidentiality.
 
14.8
This Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes all negotiations, undertakings, agreements, representations or warranties, whether oral or written, by any officer,

 
 
13

 
 
employee or representative of the Company or any party thereto; and any prior agreement of the parties hereto or of the Employee and the Company in respect of the subject matter contained herein is hereby terminated and cancelled. Any modification to the Agreement can only be made in writing, signed by the Employee and the CEO, with the approval of the Board.
 
14.9 
It is hereby agreed between the parties that the laws of the State of Israel shall apply to this Agreement and that the sole and exclusive place of jurisdiction in any matter arising out of or in connection with this Agreement shall be the applicable Tel-Aviv court.

 
 
IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date.

/s/ Andrew L. Pearlman  
/s/ Stephen Bellomo
 
MEDGENICS, MEDICAL ISRAEL LTD.
 
Stephen Bellomo
 
By: Dr. Andrew L. Pearlman, CEO
     
 
 
 
 
14

 
EXHIBIT A
 
Goal Bonus Criteria Through March 2008
 
The total Goal Bonus of $20,000 shall be allocated to the achievement of the following through March 2008:
 
1.
10% for Updated Master Plan Updated Master Plan to get to successful start of EPODURE Trial in first patients starting in Q1/08, approved by the CEO, with sign-on by all key parties
 
2.
10% for Devices Master Plan: Clear specifications, schedule, budget, core team, key outsourcing, updated MDR and regulatory approval plan, for Derma Vac Harvester, Implanter, Locator/Ablator and Bioreactor, approved by the CEO
 
3.
25% for Trial-ready set of Devices:   Harvester, Implanter Locator/Ablator tested, ready and regulatory approved for trial
 
4.
15% for updated Bioreactor and cassette design; Projecting full scale production costs per-patient under $100 for all consumed materials (besides vector) to produce 4 biopumps.
 
5. 
40% for actual successful implantation in first patients of EPODURE trial Ql/08
 

 
 
15

 
EXHIBIT B
 
Team Leadership Bonus Criteria for the period through March 2008
 
The CEO and the Board will evaluate the Employee’s performance after for the period through March 2008 and the Team Leadership Bonus of $15,000 will be awarded based on the overall average score (as determined by the CEO and the Board) earned by Employee in the areas listed below.
 
5 (exceeds expectations) =
110% bonus
4 (very good) =
100% bonus
3 (OK) =
80% bonus
2 (needs improvement) =
50% bonus
1 (seriously deficient) =
20% bonus
 
1.
Teamwork: Helping to organize and maintain a team spirit, with good communication, and fruitful cooperation among the team — both in Employee’s own area of responsibility and with other parts of the organization — and put team success ahead of Employee’s own personal ambitions/parochial objectives
 
2.
Proactive orientation: Having eyes always open to optimize the plan, to seize opportunities to achieve goals, to spot ways to avoid problems and delays, and to prevent mistakes or minimize downside if unavoidable.
 
3.
Advocate for Company/strategy: vigorous supporter of the Company, its leadership, its technology, its strategy, speaking both internally and externally to enhance support
 
4. 
Energy; Devoting vigorous effort, dedication, and great energy to the tasks
 
5.
Courage: Confronting and deal with thorny or uncomfortable issues that need to be dealt, to make “out of the box” proposals that will have a positive impact on company timelines AND quality of the work product
 
6.
Improvisation/creative problem-solving: Finding ways around or through a “no” and not accept it as an answer, to seek ways to move up schedules by suppliers and by the Company; Engineer and optimize the GANTT and its execution on an ongoing basis, to achieve goals earlier and better
 
7.
Transparency — Admitting when there are difficulties, problems or mistakes so there are no “unpleasant surprises” or embarrassments and so other colleagues can weigh in and collaborate in problem solving
 
 
16

 
 
8.
Business acumen — Understanding the impact of Employee’s decisions on business as well as scientific success and understands “big picture” implications of actions, communication and decisions on business success and strategy execution
 
9.
Continuous learning — Willing to challenge self and keep stretching/learning, look for new methods/techniques
 
10.
Data-driven decision-making — Striving to make decisions based on factual assessments of impact on goals, not solely on conjecture or “gut feeling”, and not on ego
 
 
17